Gilead Says Remdesivir Shows Improvement in COVID-19 Patients When Used Early
1 sourceUpdated Apr 29, 2020
Gilead Sciences Inc on Wednesday said its experimental antiviral drug remdesivir helped improve outcomes for patients with COVID-19, and provided data suggesting it worked better when given earlier in the course of…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Sponsored
Coverage
Comments
Ask Genius by OpenServe:
Free account · your comment posts right after signup
Sponsored